Notes from the Field: Rollout of Nirsevimab to Protect Infants and Young Children During the Respiratory Syncytial Virus Season - New York City, 2023-2024

Published on December 5, 2024

This report describes the percentage of New York City infants born during the recommended nirsevimab adminstration period who received nirsevimab.